A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers: The Canary Prostate Cancer Tissue Microarray.
Adv Anat Pathol., Jan;20(1):39-44 (2013)
Current status of focal primary therapy for prostate cancer.
Urol. Oncol., Nov;30(6):942-3 (2012)
Employing the Epigenetic Field Defect to Detect Prostate Cancer in Biopsy-Negative Patients.
J. Urol., Nov (2012)
Contemporary Grading for Prostate Cancer: Implications for Patient Care.
Eur. Urol., Oct (2012)
Advanced clinical States in prostate cancer.
Urol. Clin. North Am., Nov;39(4):561-71 (2012)
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.
Clin. Cancer Res., Oct;18(19):5471-8 (2012)
The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
Urol. Oncol., 30(4 Suppl):S1 (2012 Jul-Aug)
Reply to circumcision unlikely to be associated with prostate cancer risk.
Cancer., Jun (2012)
Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.
J. Clin. Endocrinol. Metab., Aug;97(8):2809-17 (2012)
J Natl Compr Canc Netw., Apr;10(4):502-35 (2012)
Circumcision and the risk of prostate cancer.
Cancer., Sep;118(18):4437-43 (2012)
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial.
Urol. Oncol., Dec (2011)
Clinical roundtable monograph: new and emerging treatments for advanced prostate cancer.
Clin Adv Hematol Oncol., Jun;9(6):1-11; discussion 11-5 (2011)
J Natl Compr Canc Netw., Sep;9(9):960-77 (2011)
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
Cancer Epidemiol. Biomarkers Prev., Sep;20(9):1928-36 (2011)
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity.
Genome Res., Sep;21(9):1450-61 (2011)
Hospital-level variation in the quality of urologic cancer surgery.
Cancer., Feb;118(4):987-96 (2012)
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.
Am. J. Epidemiol., Jun;173(12):1419-28 (2011)
The effect of demographic and clinical factors on the relationship between BMI and PSA levels.
Prostate., Nov;71(15):1631-7 (2011)
Influence of publication of US and European prostate cancer screening trials on PSA testing practices.
J. Natl. Cancer Inst., Mar;103(6):520-3 (2011)